Market Overview

UPDATE: RBC Capital Sees Arrowhead Research Potentially Attractive M&A, Partnering Interest from Bristol, Merck, Novartis

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ARWR

DateFirmActionFromTo
May 2016Chardan CapitalInitiates Coverage onBuy
Sep 2015Piper JaffrayMaintainsOverweight
Apr 2015JefferiesDowngradesBuyHold

View More Analyst Ratings for ARWR
View the Latest Analyst Ratings

Posted-In: Analyst Color News Rumors M&A Analyst Ratings

 

Related Articles (ARWR)